Transcription of CDSCO - Guidance for Industry
{{id}} {{{paragraph}}}
Submission of Clinical Trial Application for Evaluating Safety and Efficacy Requirements for permission of New Drugs Approval Post approval changes in biological products: Quality safety and Efficacy Documents Preparation of the Quality Information for Drug Submission for New Drug Approval: Biotechnological/Biological Products Guidance for Industry Central Drugs Standard Control Organization Ministry of Health | Govt. of India Guidance for Industry Central Drugs Standard Control Organization Page 2 Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy (General considerations for conducting Clinical Trial as per Drugs and Cosmetics Act 1940 and Rules 1945) Document No.
Human or animal origin (If any) and its TSE / BSE compliance 3.1.2 Description of Manufacturing Process and Process Control 3.1.3 Process flow chart Operations flow sheet 3.1.4 In process control steps & intermediates Include process control step at each stage of Drug substance 3.2 Characterization of Drug substance
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}